{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T12:58:21Z","timestamp":1789995501267,"version":"4.0.1"},"reference-count":36,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,7]]},"DOI":"10.1097\/hco.0b013e3283021c82","type":"journal-article","created":{"date-parts":[[2008,5,30]],"date-time":"2008-05-30T03:12:27Z","timestamp":1212117147000},"page":"393-398","source":"Crossref","is-referenced-by-count":33,"title":["Nicotinic acid: recent developments"],"prefix":"10.1097","volume":"23","author":[{"given":"Vaijinath S","family":"Kamanna","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony","family":"Vo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moti L","family":"Kashyap","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-18-20210204","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/0003-9861(55)90070-9","article-title":"Influence of nicotinic acid on serum cholesterol in man","volume":"54","author":"Altschul","year":"1955","journal-title":"Arch Biochem Biophys"},{"key":"R2-18-20210204","doi-asserted-by":"crossref","first-page":"549","DOI":"10.2217\/17460875.1.5.549","article-title":"Effect of niacin on lipoproteins and atherosclerosis","volume":"1","author":"Ganji","year":"2006","journal-title":"Future Lipidol"},{"key":"R3-18-20210204","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1097\/00041433-200412000-00006","article-title":"Niacin therapy in atherosclerosis","volume":"15","author":"Myers","year":"2004","journal-title":"Curr Opin Lipidol"},{"key":"R4-18-20210204","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1111\/j.1365-2796.2005.01528.x","article-title":"Nicotinic acid: the broad spectrum lipid drug. A 50th anniversary review","volume":"258","author":"Carlson","year":"2005","journal-title":"J Intern Med"},{"key":"R5-18-20210204","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1056\/NEJMoa011090","article-title":"Simvastatin and niacin, antioxidant vitamins, or the combination for the prevention of coronary disease","volume":"345","author":"Brown","year":"2001","journal-title":"N Engl J Med"},{"key":"R6-18-20210204","doi-asserted-by":"crossref","first-page":"3512","DOI":"10.1161\/01.CIR.0000148955.19792.8D","article-title":"Arterial biology for the investigation of the treatment effects of reducing cholesterol (ARBITER 2). A double-blind, placebo-controlled study of extended-release niacin on atherosclerosis progression in secondary prevention patients treated with statin","volume":"110","author":"Taylor","year":"2004","journal-title":"Circulation"},{"key":"R7-18-20210204","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1185\/030079906X148508","article-title":"The effect of 24 months of combination statin and extended-release niacin on carotid intima-media thickness: ARBITER 3","volume":"22","author":"Taylor","year":"2006","journal-title":"Curr Med Res Opin"},{"key":"R8-18-20210204","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.jacl.2007.05.003","article-title":"Niacin plus simvastatin reduces coronary stenosis progression among patients with metabolic syndrome despite a modest increase in insulin resistance: a subgroup analysis of the HDL\u2013 atherosclerosis treatment study","volume":"1","author":"Vittone","year":"2007","journal-title":"J Clin Lipidol"},{"key":"R9-18-20210204","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1001\/archinte.164.7.697","article-title":"New perspectives on the use of niacin in the treatment of lipid disorders","volume":"164","author":"McKenney","year":"2004","journal-title":"Arch Intern Med"},{"key":"R10-18-20210204","doi-asserted-by":"crossref","first-page":"3634","DOI":"10.1172\/JCI23626","article-title":"GPR109A (PUMA-G\/HM74A) mediates nicotinic acid-induced flushing","volume":"115","author":"Benyo","year":"2005","journal-title":"J Clin Invest"},{"key":"R11-18-20210204","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.1124\/mol.106.030833","article-title":"Nicotinic acid-induced flushing is mediated by activation of epidermal Langerhans cells","volume":"70","author":"Benyo","year":"2006","journal-title":"Mol Pharm"},{"key":"R12-18-20210204","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.jacl.2007.07.008","article-title":"Revisiting niacin: reviewing the evidence","volume":"1","author":"Vaccari","year":"2007","journal-title":"J Clin Lipidol"},{"key":"R13-18-20210204","doi-asserted-by":"crossref","first-page":"633","DOI":"10.5414\/CPP44633","article-title":"Improved control of niacin-induced flushing using an optimized once-daily, extended-release niacin formulation","volume":"44","author":"Cefali","year":"2006","journal-title":"Int J Clin Pharmacol Ther"},{"key":"R14-18-20210204","doi-asserted-by":"crossref","first-page":"78","DOI":"10.5414\/CPP45078","article-title":"Aspirin reduces cutaneous flushing after administration of an optimized extended-release niacin formulation","volume":"45","author":"Cefali","year":"2007","journal-title":"Int J Clin Pharmacol Ther"},{"key":"R15-18-20210204","doi-asserted-by":"crossref","first-page":"6682","DOI":"10.1073\/pnas.0601574103","article-title":"Antagonism of the prostaglandin D2 receptor1 suppresses nicotinic acid-induced vasodilation in mice and humans","volume":"103","author":"Cheng","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R16-18-20210204","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1038\/sj.clpt.6100180","article-title":"Suppression of niacin-induced vasodilation with an antagonist to prostaglandin D2 receptor subtype 1","volume":"81","author":"Lai","year":"2007","journal-title":"Clin Pharmacol Ther"},{"key":"R19-18-20210204","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1038\/nm824","article-title":"PUMA-G and HM74 are receptors for nicotinic acid and mediate its antilipolytic effect","volume":"9","author":"Tunaru","year":"2003","journal-title":"Nat Med"},{"key":"R20-18-20210204","doi-asserted-by":"crossref","first-page":"9869","DOI":"10.1074\/jbc.M210695200","article-title":"Molecular identification of high and low affinity receptors for nicotinic acid","volume":"278","author":"Wise","year":"2003","journal-title":"J Biol Chem"},{"key":"R21-18-20210204","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/S0006-291X(03)00342-5","article-title":"Molecular identification of nicotinic acid receptor","volume":"303","author":"Soga","year":"2003","journal-title":"Biochem Biophys Res Commun"},{"key":"R22-18-20210204","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1194\/jlr.M300403-JLR200","article-title":"Niacin noncompetitively inhibits DGAT2 but not DGAT1 activity in HepG2 cells","volume":"45","author":"Ganji","year":"2004","journal-title":"J Lipid Res"},{"key":"R23-18-20210204","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1161\/01.ATV.19.4.1051","article-title":"Niacin accelerates intracellular apo B degradation by inhibiting triacylglycerol synthesis in human hepatoblastoma (Hep G2) cells","volume":"19","author":"Jin","year":"1999","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"R24-18-20210204","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1111\/j.0954-6820.1962.tb07203.x","article-title":"The effect of nicotinic acid on the plasma free fatty acids","volume":"172","author":"Carlson","year":"1962","journal-title":"Acta Med Scand"},{"key":"R25-18-20210204","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1111\/j.0954-6820.1963.tb17457.x","article-title":"Studies on the effect of nicotinic acid on catecholamine stimulated lipolysis in adipose tissue in vitro","volume":"173","author":"Carlson","year":"1963","journal-title":"Acta Med Scand"},{"key":"R26-18-20210204","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1172\/JCI108833","article-title":"High density lipoprotein metabolism in man","volume":"60","author":"Blum","year":"1977","journal-title":"J Clin Invest"},{"key":"R27-18-20210204","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1172\/JCI109385","article-title":"Effect of nicotinic acid therapy on plasma high density lipoprotein subfraction distribution and composition and on apolipoprotein A metabolism","volume":"63","author":"Shepherd","year":"1979","journal-title":"J Clin Invest"},{"key":"R28-18-20210204","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1161\/01.ATV.17.10.2020","article-title":"Niacin decreases removal of high density lipoprotein apolipoprotein A-I but not cholesterol ester by Hep G2 cells. Implications for reverse cholesterol transport","volume":"17","author":"Jin","year":"1997","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"R29-18-20210204","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1126\/science.271.5248.518","article-title":"Identification of scavenger receptor SR-BI as a high density lipoprotein receptor","volume":"271","author":"Acton","year":"1996","journal-title":"Science"},{"key":"R30-18-20210204","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/nature01250","article-title":"Ectopic beta-chain of ATP synthase is an apolipoprotein A-I receptor in hepatic HDL endocytosis","volume":"421","author":"Martinez","year":"2003","journal-title":"Nature"},{"key":"R32-18-20210204","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.bcp.2003.09.014","article-title":"Stimulation of CD36 and the key effector of reverse cholesterol transport ATP-binding cassette A1 in monocytoid cells by niacin","volume":"67","author":"Rubic","year":"2004","journal-title":"Biochem Pharmacol"},{"key":"R33-18-20210204","first-page":"125","article-title":"Niacin inhibits LDL oxidation and redox-sensitive VCAM-1 and MCP-1 expression in human aortic endothelial cells [abstract].","volume":"24","author":"Ganji","year":"2004","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"R34-18-20210204","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/j.amjcard.2006.04.011","article-title":"Effects of extended-release niacin on lipoprotein particle size, distribution, and inflammatory markers in patients with coronary artery disease","volume":"98","author":"Kuvin","year":"2006","journal-title":"Am J Cardiol"},{"key":"R35-18-20210204","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/0090-6980(89)90088-9","article-title":"Release of markedly increased quantities of prostaglandin D2 in vivo in humans following the administration of nicotinic acid","volume":"38","author":"Morrow","year":"1989","journal-title":"Prostaglandins"},{"key":"R36-18-20210204","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.1124\/mol.106.030833","article-title":"Nicotinic acid-induced flushing is mediated by activation of epidermal langerhans cells","volume":"70","author":"Benyo","year":"2006","journal-title":"Mol Pharmacol"},{"key":"R37-18-20210204","doi-asserted-by":"crossref","first-page":"2637","DOI":"10.1038\/sj.jid.5700586","article-title":"Langerhans cells release prostaglandin D2 in response to nicotinic acid","volume":"126","author":"Maciejewski-Lenoir","year":"2006","journal-title":"J Invest Dermatol"},{"key":"R38-18-20210204","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.atherosclerosis.2006.07.014","article-title":"Nicotinic acid induces secretion of prostaglandin D2 in human macrophages: an in vitro model of the niacin flush","volume":"192","author":"Meyers","year":"2007","journal-title":"Atherosclerosis"},{"key":"R39-18-20210204","doi-asserted-by":"crossref","first-page":"6682","DOI":"10.1073\/pnas.0601574103","article-title":"Antagonism of the prostaglandin D2 receptor 1 suppresses nicotinic acid-induced vasodilation in mice and humans","volume":"103","author":"Cheng","year":"2006","journal-title":"Proc Natl Acad Sci USA"}],"container-title":["Current Opinion in Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/HCO.0b013e3283021c82","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T17:11:11Z","timestamp":1786036271000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00001573-200807000-00018"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,7]]},"references-count":36,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2008]]}},"URL":"https:\/\/doi.org\/10.1097\/hco.0b013e3283021c82","relation":{},"ISSN":["0268-4705"],"issn-type":[{"value":"0268-4705","type":"print"}],"subject":[],"published":{"date-parts":[[2008,7]]}}}